|
|
| Research article summary (published 16 Jun 2008): |
Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo.
Full Abstract
The symptoms of major psychotic illness are diverse and vary widely across individuals. Furthermore, the prepsychotic phase is indistinct, providing little indication of the precise pattern of symptoms that may subsequently emerge. Likewise, although in some individuals who have affected family members the occurrence of disease may be predicted, the specific symptom profile may not. An important question, therefore, is whether predictive physiological markers of symptom expression can be identified. We conducted a placebo-controlled, within-subjects study in healthy individuals to investigate whether individual variability in baseline physiology, as assessed using functional magnetic resonance imaging, predicted psychosis elicited by the psychotomimetic drug ketamine and whether physiological change under drug reproduced those reported in patients. Here we show that brain responses to cognitive task demands under placebo predict the expression of psychotic phenomena after drug administration. Frontothalamic responses to a working memory task were associated with the tendency of subjects to experience negative symptoms under ketamine. Bilateral frontal responses to an attention task were also predictive of negative symptoms. Frontotemporal activations during language processing tasks were predictive of thought disorder and auditory illusory experiences. A subpsychotic dose of ketamine administered during a second scanning session resulted in increased basal ganglia and thalamic activation during the working memory task, paralleling previous reports in patients with schizophrenia. These results demonstrate precise and predictive brain markers for individual profiles of vulnerability to drug-induced psychosis.
Learn Faster Today Improve your study skills
Author information
Author/s: Honey, Garry D (GD); Corlett, Philip R (PR); Absalom, Anthony R (AR); Lee, Michael (M); Pomarol-Clotet, Edith (E); Murray, Graham K (GK); McKenna, Peter J (PJ); Bullmore, Edward T (ET); Menon, David K (DK); Fletcher, Paul C (PC);
Affiliation: Department of Psychiatry, Brain Mapping Unit and Behavioural and Clinical Neurosciences Institute, University of Cambridge, School of Clinical Medicine, Cambridge CB2 2QQ, United Kingdom.
Grants: (Agency:United Kingdom Wellcome Trust)
Journal and publication information
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience (J Neurosci), published in United States. (Language: eng)
Reference: 2008-Jun; vol 28 (issue 25) : pp 6295-303
Dates: Created 2008/06/19; Completed 2008/07/10;
PMID: 18562599, status: MEDLINE (last retrieval date: 11/6/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
Related articles
These are the highest related articles currently in the database:
- Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis.
30 May 2006 - Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study.
20 Oct 2005 - Iontophoretic administration of S(+)-ketamine in patients with intractable central pain: a placebo-controlled trial.
Oct 2005 - Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man.
29 Apr 2007 - Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
30 Jan 2008 - Bowel function after bowel surgery: morphine with ketamine or placebo; a randomized controlled trial pilot study.
18 Aug 2007 - Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval task.
10 Oct 2005 - Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans.
30 May 2007 - The psychotomimetic states inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis.
31 Mar 2008 - Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man.
17 Oct 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.